M. Combe

HER2 Status in Ovarian Carcinomas: A Multicenter GINECO Study of 320 Patients

Marianne Tuefferd, Jérôme Couturier, Frédérique Penault–Llorca et al. · PLoS ONE · 2007 · 185 citations · Full text

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet · 2019 · 125 citations

Breast Oncology, Oncology, Early Breast Cancer +6

Second-line chemotherapy with pegylated liposomal doxorubicin and carboplatin is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trial

Jean-­Marc Ferrero, B. Weber, J.-F. Geay et al. · Annals of Oncology · 2006 · 105 citations · Full text

Pegylated Liposomal Doxorubicin, Late Relapse, Medicine +8

A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: Final results

Jacques Rouëssé, Brigitte De La Lande, F. Bertheault-Cvitkovic et al. · International Journal of Radiation Oncology*Biology*Physics · 2006 · 75 citations

Radiation Medicine, Surgical Oncology, Breast Oncology +8

Endopyelotomy with the Acucise Cutting Balloon Device

A. Gelet, M. Combe, J. M. Ramackers et al. · European Urology · 1997 · 49 citations

Oculoplastics, Minimally Invasive Procedure, Surgery +3